Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

McGill University

$627,300.00

Large-scale neurobiologically-informed phenotyping of cognition and behaviour in Parkinson's disease

FY 2021-22

Summary
Cognitive and behavioural symptoms in Parkinson's disease vary immensely. Some patients develop significant apathy or so much difficulty with concentration that they have to give up a hobby, while others take up boxing or plan local support groups. Currently, we mainly focus on measuring the severity of a patient's cognitive and behavioural symptoms, rather than honing in on identifying why patients differ so much. Meanwhile, these differences could provide important clues about: 1) the changes occurring in the brain, and 2) about the other factors in a person's life that could affect these symptoms (e.g. stress). One key reason why it has been difficult to properly measure the differences in cognitive and behavioural symptoms that arise between patients is that very large groups of patients are required and precise tests of cognition and behaviour are hard to perform on such a large scale. The first goal of this research program is therefore to establish that remote (i.e. from home) web-based testing of cognition and behaviour can be used as an alternative to in-person testing, thereby allowing us to significantly expand the reach of clinical research studies of cognition. The second goal is to identify tests of cognition that can track specific brain changes in Parkinson's patients so that we can begin to understand the brain basis of differences between patients. The third goal is to consider all of the symptoms at once to examine how they are related to one another (e.g. if a patient is more distractible, it is also the case that they are more likely to be depressed?) and to find factors in a person's brain or life that explain these relationships (e.g. are neurochemical changes a better predictor of these symptoms or is life stress a better predictor?). Better understanding these relationships will allow us to know when to offer someone a medication or when to offer them support for other areas of life.
Program
Project Grant
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
452752
Name
Sharp Madeleine E
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Behavioural Sciences - B-2
Projecttitle
Large-scale neurobiologically-informed phenotyping of cognition and behaviour in Parkinson's disease
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$627,300
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Attention; Brain Imaging; Cognitive Impairment; Locus Coeruleus; Nucleus Basalis Of Meynert; Parkinson'S Disease; Psychiatric Symptoms; Reward; Substantia Nigra
Abstract
Cognitive and behavioural symptoms in Parkinson's disease vary immensely. Some patients develop significant apathy or so much difficulty with concentration that they have to give up a hobby, while others take up boxing or plan local support groups. Currently, we mainly focus on measuring the severity of a patient's cognitive and behavioural symptoms, rather than honing in on identifying why patients differ so much. Meanwhile, these differences could provide important clues about: 1) the changes occurring in the brain, and 2) about the other factors in a person's life that could affect these symptoms (e.g. stress). One key reason why it has been difficult to properly measure the differences in cognitive and behavioural symptoms that arise between patients is that very large groups of patients are required and precise tests of cognition and behaviour are hard to perform on such a large scale. The first goal of this research program is therefore to establish that remote (i.e. from home) web-based testing of cognition and behaviour can be used as an alternative to in-person testing, thereby allowing us to significantly expand the reach of clinical research studies of cognition. The second goal is to identify tests of cognition that can track specific brain changes in Parkinson's patients so that we can begin to understand the brain basis of differences between patients. The third goal is to consider all of the symptoms at once to examine how they are related to one another (e.g. if a patient is more distractible, it is also the case that they are more likely to be depressed?) and to find factors in a person's brain or life that explain these relationships (e.g. are neurochemical changes a better predictor of these symptoms or is life stress a better predictor?). Better understanding these relationships will allow us to know when to offer someone a medication or when to offer them support for other areas of life.
Competitiondate
202109
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Sharp, Madeleine E
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $627,300~ $0~